<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02512146</url>
  </required_header>
  <id_info>
    <org_study_id>2015SDU-QILU-G03</org_study_id>
    <nct_id>NCT02512146</nct_id>
  </id_info>
  <brief_title>The Expression of the Ionotropic Glutamate Receptors in Colon of IBS</brief_title>
  <official_title>The Expression of the Ionotropic Glutamate Receptors in Colon of IBS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to determine the expression of the ionotropic glutamate receptors in colon of
      irritable bowel syndrome (IBS) patients and evaluate the relationship between the ionotropic
      glutamate receptors and IBS symptoms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ionotropic glutamate receptors participate in pain in nervous system. In this
      study,participants will examine the expression of the ionotropic glutamate receptors in colon
      of irritable bowel syndrome (IBS) patients and evaluate the relationship between the
      ionotropic glutamate receptors and IBS symptoms.

      Participants may futher study the mechanism using cell experiment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>the expression of the ionotropic glutamate receptors</measure>
    <time_frame>4 months</time_frame>
    <description>Participants will examine the expression level of ionotropic glutamate receptors using quantitative real-time RT-PCR and western blot ,examine the distribution using immunohistochemy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the relationship between the ionotropic glutamate receptors and IBS symptom</measure>
    <time_frame>6 months</time_frame>
    <description>Symptoms will be assessed though the severity of abdominal pain or discomfort and seizure frequency.Participants will evaluate the relationship between the expression level or the distribution of ionotropic glutamate receptors and IBS symptom. If there is a link between them, participants will study the underlying molecular mechanisms.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Irritable bowel syndrome</arm_group_label>
    <description>Patients meeting Rome III criteria of irritable bowel syndrome. Intervention: colonoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal controls</arm_group_label>
    <description>Asymptomatic individuals for health surveillance or patients for follow up after polypectomy.
Intervention: colonoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>colonoscopy</intervention_name>
    <description>Patients will undergo colonoscopy and participants will get biopsies from the colon.</description>
    <arm_group_label>Irritable bowel syndrome</arm_group_label>
    <arm_group_label>Normal controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Taken biopsies during Colonoscopy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients underwent colonoscopy in Qilu Hospital outpatient and inpatient department.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients meeting IBS Rome III criteria. Asymptomatic individuals for health surveillance or
        patients for follow up after polypectomy.

        Exclusion Criteria:

        Patients with known cancers or abdominal surgery. Alarm symptoms such as anaemia,
        gastrointestinal bleeding or obstruction, marked weight loss, abdominal mass. Patients who
        are unwilling to sign or give the informed consent form. Patients with impaired cardiac,
        liver or renal function. Patients with coagulopathy. Patients with pregnancy or
        breastfeeding.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>xiuli zuo, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Department of Gastroenterology, Qilu Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>xiuli zuo, PHD</last_name>
    <phone>15588818685</phone>
    <phone_ext>0531-88369277</phone_ext>
    <email>xiulizuo@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Gastroenterology, Qilu Hospital, Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>xiuli zuo, PHD</last_name>
      <phone>15588818685</phone>
      <phone_ext>0531-88369277</phone_ext>
      <email>xiulizuo@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2015</study_first_submitted>
  <study_first_submitted_qc>July 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2015</study_first_posted>
  <last_update_submitted>July 27, 2015</last_update_submitted>
  <last_update_submitted_qc>July 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Yanqing Li</investigator_full_name>
    <investigator_title>Vice president of Qilu Hospital</investigator_title>
  </responsible_party>
  <keyword>IBS</keyword>
  <keyword>Ionotropic glutamate receptors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

